Duchenne Muscular Dystrophy and Its Hopeful Future
(Image Credit: Mayo Clinic)
(Image Credit: iStock)
(Image Credit: Penn Medicine)
November 22, 2023
Lily Sharkey
11th Grade
Dominican Academy
Every person has more than 20,000 genes that code for their very existence. Genes are made up of deoxyribonucleic acid (DNA) wound up into tight structures called chromosomes. All chromosomes are found in the nucleus, the core structure of each cell. Every person has two replicas of each gene, one inherited from each parent. A mutation, which is a variant or alteration in the DNA, can drastically change what the DNA codes for. The variant can be benign, meaning they don’t pose a serious threat to one’s health, or pathogenic, which causes genetic and health issues.
Genetic disorders are just that— diseases caused by a pathogenic variation in a gene. Some genetic disorders are inherited at birth, while others develop later in life. A person can even be a carrier for a disease, meaning they’ve inherited the mutation from their parents, but don’t exhibit symptoms. Genetic disorders can be chromosomal, multifactorial, or monogenic. Chromosomal genetic disorders are caused by a mutation on the chromosome, such as missing or duplicated chromosomal material. Multifactorial genetic disorders are caused by a mix of genetic and environmental factors, such as chemical/radiation exposure, diet, smoking, or UV exposure; scientists still don’t fully understand how these exposures lead to DNA mutations. Monogenic genetic diseases are caused by one gene mutation.
Genetic disorders are identified through a series of tests, such as carrier testing, which is a blood test that identifies whether one has any of the gene mutations linked to certain genetic disorders. This test is encouraged for everyone considering pregnancy, even if there is no history of genetic disorders in the family. Prenatal screening, on the other hand, is performed on pregnant patients to determine the probability of the fetus having any type of chromosomal disease. Prenatal diagnostic testing uses amniotic fluid from the uterus to determine whether the fetus is at a higher risk for genetic disorders.
Lastly, newborn screening is performed on a newborn baby to detect genetic disorders early; if they are caught early, it can help the patient receive appropriate treatment.
Although many genetic disorders are yet to have a cure, certain treatments do exist to improve a patient’s quality of life. Some of these treatments include medication to minimize symptoms, chemotherapy to control atypical cell growth, blood transfusion to regenerate normal levels of blood cells, surgery to repair complications, and organ transplant. Of course, appropriate treatment depends on the individual’s genetic disorder, symptoms, and complications, and there is seldom a uniform treatment that can be applied to all patients. There is little that can be done to prevent a genetic disorder, as the causes are found in the fundamental genome of a person.
Genetic disorders can either be dominant or recessive. Dominant inheritance only requires one mutated gene from either parent to express the disease. There is a 50% chance of a child inheriting a dominant genetic disorder if one of the parents has one. Recessive inheritance requires the mutated gene from both parents. If both parents are carriers of a genetic disorder, there is a 25% chance that the child will inherit the mutated gene from both parents and express the disease, a 50% chance that the child will inherit the mutated gene from one parent and be a mere carrier, and a 25% chance that the child will not inherit the mutated gene from either parent and will not be a carrier or express the disease.
Duchenne Muscular Dystrophy (DMD) is an example of an X-linked recessive genetic disorder that causes muscle weakness and degeneration. DMD predominantly manifests in individuals with XY chromosomes (those assigned male at birth). Duchenne Muscular Dystrophy is caused by the DMD gene, the second-largest human gene that encodes dystrophin. This muscle protein allows muscles to recover from physical strains resulting from typical movement. Patients with DMD create little to no dystrophin, meaning that their cells weaken and eventually die. DMD often affects the lower limbs, but it can also manifest in the muscles of internal organs like the diaphragm, making breathing difficult. Other symptoms include pseudohypertrophy, the “false enlargement” of muscles (such as calf muscles) due to a buildup of fat and connective tissue that replaces muscle cells that have died, and cardiomyopathy, progressive heart enlargement. Due to these cardiovascular and respiratory complications, the life expectancy of those with DMD is from their mid-to-late 20s.
DMD is X-linked, meaning it is connected to the X chromosome. Because DMD is recessive, a person needs two copies of the gene mutation to express the disease. However, because males only have one X chromosome, they only need one copy of the mutated gene; this is why DMD primarily presents itself in males. Females with XX chromosomes may be carriers for the gene, but will most likely only inherit one affected gene. Thus, they are still able to create enough dystrophin and not be impacted. XY children of carrier mothers have a 50% chance of inheriting the mutated gene; they do not receive the gene from a carrier father, as children receive their X chromosome from their mother. However, DMD can be caused by a new mutation in the mother’s ova (egg cells) because the large size of the DMD gene makes it vulnerable to mutations.
(Image Credit: Computational Genomics Research Group, University of California, Berkley)
Up until recently, there was no cure for DMD. Treatments instead focused on alleviating symptoms and moderating the development of the disease. However, as of June 22, 2023, the U.S. Food and Drug Association (FDA) approved Elevidys, the first gene therapy treatment for DMD for pediatric patients aged 4-5. Gene therapy is the introduction of a functional gene into the genome of a patient’s cell in order to repair the mutated gene. Gene therapy for DMD works by creating a smaller version of the DMD gene called micro-dystrophin; this smaller manufactured size allows the gene to be inserted into an adeno-associated virus (AAV), which is the viral vector that will carry the corrected gene to the genome. Elevidys is a one-time treatment as opposed to a lifetime of mitigating remedies.
(Image Credit: Sarepta Therapeutics)
In summary, genetic disorders are mutations in one’s DNA or chromosomes. Although there is often no way to prevent genetic diseases, it is possible to undergo screenings and counseling to determine the probability of a child having a genetic disease. If the genetic disease is identified early on, then the child can begin treatments to manage symptoms and prevent complications. With further scientific exploration, it is hopeful that more genetic disorders will have treatments in the future as Duchenne Muscular Dystrophy does.
Reference Sources
Clinic, Cleveland. “Genetic Disorders: What Are They, Types, Symptoms & Causes.” Cleveland Clinic, 2021,
https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders. Accessed 1 Nov. 2023.
“Duchenne Muscular Dystrophy: Causes, Symptoms, and Treatment | Pfizer.” Pfizer.com, 2021,
“Dystrophin.” Berkeley.edu, 2023,
https://compbio.berkeley.edu/people/ed/rust/Dystrophin.html. Accessed 1 Nov. 2023.
“Genetic Disorders.” Genome.gov, 2019,
https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders. Accessed 1 Nov. 2023.
“Gene Therapy.” Genome.gov, 2023,
https://www.genome.gov/genetics-glossary/Gene-Therapy#:~:text=Gene%20therapy%20is%20a%20technique,healthy%20version%20of%20that%20gene. Accessed 1 Nov. 2023.
“How Is Genetic Disease Inherited?” Givf.com, 2017,
https://givffertility.com/genetics/reproductive-genetics-overview-faqs/#:~:text=Dominant%20genetic%20diseases%20are%20caused,one%20gene%20occurs%20at%20conception. Accessed 1 Nov. 2023.
“Inheritance Patterns of Abnormal Genes (Mutations).” Mayo Clinic, 2020,
https://www.mayoclinic.org/tests-procedures/genetic-testing/multimedia/genetic-disorders/sls-20076216?s=6. Accessed 1 Nov. 2023.
“Muscular Dystrophy | ASGCT - American Society of Gene & Cell Therapy |.” Asgct.org, 2021,
https://patienteducation.asgct.org/disease-treatments/muscular-dystrophy. Accessed 1 Nov. 2023.
Office. “FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy.” U.S. Food and Drug
https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-certain-patients-duchenne-muscular-dystrophy. Accessed 1 Nov. 2023.
“Pathway behind Muscle Breakdowns in Duchenne Muscular Dystrophy Discovered - Penn Medicine.” Pennmedicine.org, 2021,
https://www.pennmedicine.org/news/news-releases/2021/may/pathway-behind-muscle-breakdowns-in-duchenne-muscular-dystrophy-discovered. Accessed 1 Nov. 2023.
“Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy | Sarepta Therapeutics, Inc.” Sarepta Therapeutics, Inc., 2023,
https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-fda-approval-elevidys-first-gene. Accessed 1 Nov. 2023.